SLC38A2 and neoplasm: cDC1s and tumor cells compete for glutamine in the tumor microenvironment via the transporter protein SLC38A2 to modulate anti-tumor immunity, and glutamine is the key amino acid promoting the antigen-presenting function of cDC1s77.